Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-19 Sale | 2024-08-21 4:00 pm | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 16,496 | $2.9633 | $48,883 | 220,315 (Direct) | View |
| 2024-08-14 Sale | 2024-08-16 4:47 pm | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 31,505 | $2.7687 | $87,228 | 319,868 (Direct) | View |
| 2024-05-29 Sale | 2024-05-31 4:07 pm | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 53,368 | $2.5504 | $136,110 | 214,433 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-19 Exercise | 2024-08-21 4:00 pm | N/A 2024-11-24 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 16,496 | $0 | 220,315 (Direct) | View |
| 2024-08-19 Exercise | 2024-08-21 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 16,496 | $1.43 | 220,315 (Direct) | View |
| 2024-08-14 Exercise | 2024-08-16 4:47 pm | N/A 2024-11-24 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 31,505 | $0 | 319,868 (Direct) | View |
| 2024-08-14 Exercise | 2024-08-16 4:47 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 31,505 | $1.43 | 319,868 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 4:07 pm | N/A 2024-07-01 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 59,354 | $0 | 214,433 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 4:07 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 59,354 | $2.19 | 214,433 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 4:42 pm | N/A 2034-02-14 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-16 5:23 pm | N/A 2033-02-15 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 187,500 | $0 | 187,500 (Direct) | View |
| 2022-09-19 Option Award | 2022-09-19 4:30 pm | 2022-09-19 2031-02-16 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 7,500 | $0 | 37,500 (Direct) | View |
| 2022-06-29 Option Award | 2022-07-01 4:51 pm | 2022-06-29 2031-02-16 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-02-11 Option Award(A) | 2022-07-01 4:44 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:01 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 4:15 pm | N/A 2031-02-16 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 4:22 pm | N/A 2030-02-12 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer | 60,000 | $0 | 60,000 (Direct) | View |